For Research Use Only. We do not provide direct services or products for patients.
The ready-to-use detection kit SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody Titer ELISA Kit is an enzyme-linked immunosorbent assay for the qualitative measurement of anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid antibodies in serum.
96 well microplate coated with SARS-CoV-2 Nucleocapsid-His Recombiant Protein; HRP-conjugated Goat anti-Human IgG; 20 × Dilution Buffer; 20 × Wash Buffer; Color Reagent A; Color Reagent B; Stop Solution.
SARS-CoV-2 Anti-NP Antibody
Qualitative indirect ELISA.
Qualitative measurement of anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid antibodies in serum.
Store at 2 - 8°C
The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.